Katja Berg | Global Senior Pricing and Market Access Director, Infectious Diseases, BBU
AstraZeneca

Strategic biotech and pharmaceutical leader with 25+ years of experience in science, consulting, pricing, and market access. Proven track record in delivering global and local access strategies, leading access policy, innovative pricing, contracting, and public-private partnerships. Active in shaping enterprise decisions through embedding payer and health system insight into product development and lifecycle decisions. Experienced across Europe, the Americas, and Asia, with broad therapeutic area expertise. Recognised for driving disruptive innovation, solving access constraints, and leading AI-enhanced platform development to support priority business needs.